| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9601494 | Clinical Oncology | 2005 | 7 Pages |
Abstract
Chemotherapy now has an established role in the treatment of hormone-refractory metastatic prostate cancer. This review summarises the results of the latest trials and discusses ongoing studies investigating the role of chemotherapy earlier in the disease.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
J. Graham,